Clinical, Biologic, and Prognostic Differences on the Basis of Primary Tumor Site in Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project | Zendy

Kieuhoa T. Vo | Zendy; Katherine K. Matthay | Zendy; John Neuhaus | Zendy; Wendy B. London | Zendy; Barbara Hero | Zendy; Peter F. Ambros | Zendy; Akira Nakagawara | Zendy; Doug Miniati | Zendy; Kate Wheeler | Zendy; Andrew D.J. Pearson | Zendy; Susan L. Cohn | Zendy; Steven G. DuBois | Zendy

Open Access

Clinical, Biologic, and Prognostic Differences on the Basis of Primary Tumor Site in Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project

Author(s) -

Kieuhoa T. Vo,

Katherine K. Matthay,

John Neuhaus,

Wendy B. London,

Barbara Hero,

Peter F. Ambros,

Akira Nakagawara,

Doug Miniati,

Kate Wheeler,

Andrew D.J. Pearson,

Susan L. Cohn,

Steven G. DuBois

Publication year - 2014

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2014.56.1621

Subject(s) - neuroblastoma , medicine , oncology , primary tumor , cancer , metastasis , biology , genetics , cell culture

Neuroblastoma (NB) is a heterogeneous tumor arising from sympathetic tissues. The impact of primary tumor site in influencing the heterogeneity of NB remains unclear.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Our institutional solutions Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Discover

Explore

Home ZAIA Blog